Latest & greatest articles for adhd

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on adhd or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on adhd and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

ADHD

ADHD (or Attention deficit hyperactivity disorder) is a neurodevelopmental type mental disorder. It is characterised two main categories of two types of behavioural problems:

  • inattentiveness
  • hyperactivity and impulsiveness

Most people with ADHD have problems that fall into both categories, but it doesn’t have to be the case. If a person just has inattentiveness it is referred to as attention deficit disorder (ADD).

Methylphenidate is a commonly used medication used to treat patients suffering from attention-deficit hyperactivity disorder. Methylphenidate is part of a group of drugs known as stimulants. Central nervous system stimulants help change the amounts of natural substances in the brain. But it is not the only intervention; others include Bupropion, exercise and CBT (Cognitive behavioural therapy).

Extensive ADHD research and case studies have been carried out over numerous years. Trip has unrivalled coverage of the evidence base including systematic reviews, clinical trials, clinical guidelines and case studies.

Studies are ongoing to assess the safety and effectiveness of stimulants used on children with ADHD and intellectual disabilities as well as in other populations and other interventions. Trip also includes ongoing controlled trials and ongoing systematic reviews (via the PROSPERO database).

Top results for adhd

241. Atomoxetine for attention deficit/hyperactivity disorder

for Health Technology Assessment (CCOHTA) 2003: 4 Authors' objectives To summarise the available evidence on atomoxetine (ATX) for attention deficit/hyperactivity disorder. Authors' conclusions - Seven randomized, double-blinded, controlled trials in children, adolescents and adults have shown that atomoxetine improves attention deficit/hyperactivity disorder (ADHD) symptoms compared to placebo. - There is no evidence that atomoxetine has greater efficacy or a better safety profile than currently used (...) Atomoxetine for attention deficit/hyperactivity disorder Atomoxetine for attention deficit/hyperactivity disorder Atomoxetine for attention deficit/hyperactivity disorder Garces K Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Garces K. Atomoxetine for attention deficit/hyperactivity disorder. Ottawa: Canadian Coordinating Office

2003 Health Technology Assessment (HTA) Database.

242. The use of antidepressants to treat attention deficit hyperactivity disorder in adults

standard diagnostic criteria to determine the long-term effectiveness. The tentative conclusion follows from the evidence presented, although there were several methodological weaknesses in the conduct of the review. Authors' objectives The author's objective appears to have been to evaluate the use of antidepressants for the treatment of attention deficit hyperactivity disorder (ADHD) in adults. Searching MEDLINE was searched for the year 2002; the search terms were provided. Additional articles were (...) , in adults with ADHD. Bibliographic details Maidment I D. The use of antidepressants to treat attention deficit hyperactivity disorder in adults. Journal of Psychopharmacology 2003; 17(3): 332-333 PubMedID Indexing Status Subject indexing assigned by NLM MeSH Adult; Antidepressive Agents /pharmacology /therapeutic use; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity /drug therapy; Bupropion /pharmacology /therapeutic use; Clinical Trials as Topic; Cyclohexanols /pharmacology

2003 DARE.

243. Efficacy of stimulants in adult ADHD Full Text available with Trip Pro

Efficacy of stimulants in adult ADHD Efficacy of stimulants in adult ADHD Efficacy of stimulants in adult ADHD Maidment I D CRD summary This review assessed stimulants as a treatment for adults with attention-deficit hyperactivity disorder. The quality of most of the studies was poor and there is little evidence on the effectiveness of long-term treatment. It is reasonable for the author to conclude that stimulants may be effective. Authors' objectives To assess the efficacy of stimulants (...) to treat adults with attention-deficit hyperactivity disorder (ADHD). Searching MEDLINE was searched from 1966 to 2002; the search terms were reported. The reference lists in identified articles were checked and drug manufacturers were contacted. Studies reported in English were eligible for inclusion in the review. Study selection Study designs of evaluations included in the review Eligibility criteria were not stated. The review included mostly double-blind trials of a crossover design, a few

2003 DARE.

244. Developmental trajectories of brain volume abnormalities in children and adolescents with attention-deficit/hyperactivity disorder. (Abstract)

Developmental trajectories of brain volume abnormalities in children and adolescents with attention-deficit/hyperactivity disorder. Various anatomic brain abnormalities have been reported for attention-deficit/hyperactivity disorder (ADHD), with varying methods, small samples, cross-sectional designs, and without accounting for stimulant drug exposure.To compare regional brain volumes at initial scan and their change over time in medicated and previously unmedicated male and female patients (...) with ADHD and healthy controls.Case-control study conducted from 1991-2001 at the National Institute of Mental Health, Bethesda, Md, of 152 children and adolescents with ADHD (age range, 5-18 years) and 139 age- and sex-matched controls (age range, 4.5-19 years) recruited from the local community, who contributed 544 anatomic magnetic resonance images.Using completely automated methods, initial volumes and prospective age-related changes of total cerebrum, cerebellum, gray and white matter for the 4

2002 JAMA

245. Efficacy of Adderall for attention-deficit/hyperactivity disorder: a meta-analysis

Efficacy of Adderall for attention-deficit/hyperactivity disorder: a meta-analysis Efficacy of Adderall for attention-deficit/hyperactivity disorder: a meta-analysis Efficacy of Adderall for attention-deficit/hyperactivity disorder: a meta-analysis Faraone S V, Biederman J Authors' objectives To perform a meta-analysis using data from studies of Adderall in the treatment of people with attention-deficit hyperactivity disorder (ADHD). Searching PubMed, PsycINFO, Current Contents, EMBASE (...) for attention-deficit/hyperactivity disorder: a meta-analysis. Journal of Attention Disorders 2002; 6(2): 69-75 PubMedID Indexing Status Subject indexing assigned by NLM MeSH Adolescent; Amphetamines /therapeutic use; Attention Deficit Disorder with Hyperactivity /drug therapy; Central Nervous System Stimulants /therapeutic use; Child; Child, Preschool; Humans; Randomized Controlled Trials as Topic AccessionNumber 12002006724 Date bibliographic record published 31/03/2004 Date abstract record published 31

2002 DARE.

246. A review of the research on interventions for attention deficit hyperactivity disorder: what works best

A review of the research on interventions for attention deficit hyperactivity disorder: what works best A review of the research on interventions for attention deficit hyperactivity disorder: what works best A review of the research on interventions for attention deficit hyperactivity disorder: what works best Purdie N, Hattie J, Carroll A Authors' objectives To review the effectiveness of interventions for attention deficit hyperactivity disorder (ADHD). Searching PsycLIT, MEDLINE (...) , Hattie J, Carroll A. A review of the research on interventions for attention deficit hyperactivity disorder: what works best. Review of Educational Research 2002; 72(1): 61-99 Indexing Status Subject indexing assigned by CRD MeSH Adolescent; Attention Deficit Disorder with Hyperactivity /therapy; Behavior Therapy; Central Nervous System Stimulants /therapeutic use; Child; Cognitive Therapy; Family Therapy; Methylphenidate /therapeutic use AccessionNumber 12002006678 Date bibliographic record

2002 DARE.

247. Psychopharmacology and aggression - 1: a meta-analysis of stimulant effects on overt/covert aggression-related behaviors in ADHD.

Psychopharmacology and aggression - 1: a meta-analysis of stimulant effects on overt/covert aggression-related behaviors in ADHD. Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2002 DARE.

248. Early intervention for preschool-age children with ADHD: a literature review

Early intervention for preschool-age children with ADHD: a literature review Early intervention for preschool-age children with ADHD: a literature review Early intervention for preschool-age children with ADHD: a literature review McGoey K E, Eckert T L, DuPaul G J Authors' objectives To assess the existing interventions for pre-school-age children with attention-deficit hyperactivity disorder (ADHD). Searching ERIC, PsycLIT, MEDLINE and Dissertation Abstracts were searched from 1967 to 2000 (...) assigned by CRD MeSH Attention Deficit Disorder with Hyperactivity; Child AccessionNumber 12002006279 Date bibliographic record published 31/01/2006 Date abstract record published 31/01/2006 Record Status This is a critical abstract of a systematic review that meets the criteria for inclusion on DARE. Each critical abstract contains a brief summary of the review methods, results and conclusions followed by a detailed critical assessment on the reliability of the review and the conclusions drawn

2002 DARE.

249. Novel antipsychotics for patients with attention-deficit hyperactivity disorder: a systematic review

Novel antipsychotics for patients with attention-deficit hyperactivity disorder: a systematic review Novel antipsychotics for patients with attention-deficit hyperactivity disorder: a systematic review Novel antipsychotics for patients with attention-deficit hyperactivity disorder: a systematic review Einarson T R, Iskedjian M Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been (...) made for the HTA database. Citation Einarson T R, Iskedjian M. Novel antipsychotics for patients with attention-deficit hyperactivity disorder: a systematic review. Ottawa: Canadian Coordinating Office for Health Technology Assessment (CCOHTA) 2001: 36 Authors' objectives This report aims to answer the following questions: - What does the existing evidence say about the efficacy and safety of novel antipsychotics for treating children and adolescents with attention-deficit hyperactivity disorder

2001 Health Technology Assessment (HTA) Database.

250. Atomoxetine for ADHD - horizon scanning review

. 2001 Authors' objectives To summarise the current research evidence on atomoxetine for attention deficit hyperactivity disorder (ADHD). Authors' conclusions - Clinical impact: There is likely to be a significant clinical impact from the introduction of atomoxetine due to the fact that it will be the first non-stimulant drug therapy licensed for the treatment of ADHD. - Service impact: Although there is unlikely to be a significant service impact with the introduction of atomoxetine for people (...) atomoxetine for ADHD at this time, but it may be significant if it costs more than the relatively cheap alternatives and if it draws more patients into specialist care. Timeliness warning Available on request from NHSC. Final publication URL Indexing Status Subject indexing assigned by CRD MeSH Attention Deficit Disorder with Hyperactivity /drug therapy; Child Language Published English Country of organisation England English summary An English language summary is available. Address for correspondence

2001 Health Technology Assessment (HTA) Database.

251. Effectiveness of sensory integration therapy for attention deficit hyperactivity disorder (ADHD)

Effectiveness of sensory integration therapy for attention deficit hyperactivity disorder (ADHD) Effectiveness of sensory integration therapy for attention deficit hyperactivity disorder (ADHD) Effectiveness of sensory integration therapy for attention deficit hyperactivity disorder (ADHD) Hender K Record Status This is a bibliographic record of a published health technology assessment. No evaluation of the quality of this assessment has been made for the HTA database. Citation Hender K (...) . Effectiveness of sensory integration therapy for attention deficit hyperactivity disorder (ADHD) Clayton, Victoria: Centre for Clinical Effectiveness (CCE) 2001: 7 Authors' objectives This aim of this critical appraisal was to assess the effectiveness of sensory integration therapy for attention deficit hyperactivity disorder (ADHD). Project page URL Indexing Status Subject indexing assigned by CRD MeSH Attention Deficit Disorder with Hyperactivity; Child; Occupational Therapy; Physical Therapy Modalities

2001 Health Technology Assessment (HTA) Database.

252. How efficacious and safe is short-acting methylphenidate for the treatment of attention-deficit disorder in children and adolescents: a meta-analysis

no more than 4 weeks. For all categories of primary diagnosis, and for both informants, statistically-significant methylphenidate effects were observed. Both the HI-T and HI-P estimates for attention-deficit hyperactivity disorder diagnosis studies decreased their initial methylphenidate effect estimates. The strongest teacher and parent effects were seen for ADD with hyperactivity trials, and mixed diagnosis trials, respectively. For teacher data, the magnitude of the methylphenidate effect (...) , Davey SG, Schneider M, Minder C. Bias in meta-analysis detected by a simple graphical test. BMJ 1997;315:629-34. 5. Duval S, Tweedie R. A nonparametric 'trim and fill' method of accounting for publication bias in meta-analysis. JASA 2000;95:89-98. Indexing Status Subject indexing assigned by NLM MeSH Adolescent; Adult; Age Factors; Anorexia /chemically induced; Attention Deficit Disorder with Hyperactivity /classification /drug therapy /psychology; Bias (Epidemiology); Central Nervous System

2001 DARE.

253. Cognitive rehabilitation for attention deficits following stroke. (Abstract)

Cognitive rehabilitation for attention deficits following stroke. Attention problems occur following stroke and are treated using computerised activities or paper and pencil tasks.To determine the effects of cognitive rehabilitation for attention deficits following stroke.We searched the Cochrane Stroke Group Trials Register, Medline, EMBASE, CINHAL and CLIN PSYCH databases and reference lists from relevant articles. Date of most recent searches: December 1998Controlled trials of attention (...) independence and this showed no significant effect of training.There is some indication that training improves alertness and sustained attention but no evidence to support or refute the use of cognitive rehabilitation for attention deficits to improve functional independence following stroke.

2000 Cochrane

254. Methylphenidate (Ritalin, Equasym) for attention deficit/hyperactivity disorder (ADHD) in childhood

Methylphenidate (Ritalin, Equasym) for attention deficit/hyperactivity disorder (ADHD) in childhood Methylphenidate (Ritalin, Equasym) for attention deficit/hyperactivity disorder (ADHD) in childhood Methylphenidate (Ritalin, Equasym) for attention deficit/hyperactivity disorder (ADHD) in childhood National Institute for Clinical Excellence Record Status This is a bibliographic record of a published health technology assessment. No evaluation of the quality of this assessment has been made (...) for the HTA database. Citation National Institute for Clinical Excellence. Methylphenidate (Ritalin, Equasym) for attention deficit/hyperactivity disorder (ADHD) in childhood. London: National Institute for Clinical Excellence (NICE). Technology Appraisal Guidance 13. 2000 Authors' objectives To provide guidance on the use of methylphenidate (Ritalin, Equasym) for attention deficit/hyperactivity disorder (ADHD) in childhood. Authors' conclusions Guidance 1.1 Methylphenidate is recommended for use as part

2000 Health Technology Assessment (HTA) Database.

255. The efficacy, safety, and practicality of treatments for adolescents with attention-deficit/hyperactivity disorder (ADHD)

The efficacy, safety, and practicality of treatments for adolescents with attention-deficit/hyperactivity disorder (ADHD) The efficacy, safety, and practicality of treatments for adolescents with attention-deficit/hyperactivity disorder (ADHD) The efficacy, safety, and practicality of treatments for adolescents with attention-deficit/hyperactivity disorder (ADHD) Smith B H, Waschbusch D A, Willoughby M T, Evans S Authors' objectives To review studies of interventions for adolescents diagnosed (...) with attention-deficit/hyperactivity disorder (ADHD) in order to evaluate the efficacy of the interventions. Searching MEDLINE, ERIC and PsycLIT were searched using the following keywords: 'treatment', 'adolescent', 'teen', 'ADHD', 'hyperactive', 'inattentive', and 'stimulant'. Further studies were identified from references in the review papers. No restrictions on publication language were reported. Study selection Study designs of evaluations included in the review Empirical studies were included. Specific

2000 DARE.

256. Assessment of attention deficit/hyperactivity disorder therapy: a Canadian perspective

, Otten N. Assessment of attention deficit/hyperactivity disorder therapy: a Canadian perspective. Canadian Coordinating Office for Health Technology Assessment (CCOHTA). Technology Overview Issue 3. 1999 Authors' objectives This evaluation summarizes an analysis by Miller et al. commissioned by CCOHTA. The primary purposes were: a) To critically evaluate the clinical evidence regarding the use of methylphenidate (MPH) for attention-deficit hyperactivity disorder (ADHD) in preschoolers, school-aged (...) Assessment of attention deficit/hyperactivity disorder therapy: a Canadian perspective Assessment of attention deficit/hyperactivity disorder therapy: a Canadian perspective Assessment of attention deficit/hyperactivity disorder therapy: a Canadian perspective Shukla V K, Otten N Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Shukla V K

1999 Health Technology Assessment (HTA) Database.

257. Diagnosis of attention-deficit/hyperactivity disorder

Diagnosis of attention-deficit/hyperactivity disorder Diagnosis of attention-deficit/hyperactivity disorder Diagnosis of attention-deficit/hyperactivity disorder Green M, Wong M, Atkins D Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Green M, Wong M, Atkins D. Diagnosis of attention-deficit/hyperactivity disorder. Rockville: Agency (...) Subject indexing assigned by CRD MeSH Attention Deficit Disorder with Hyperactivitys Language Published English Country of organisation United States Address for correspondence AHRQ, Center for Outcomes and Evidence Technology Assessment Program, 540 Gaither Road, Rockville, MD 20850, USA Email: AHRQTAP@ahrq.hhs.gov AccessionNumber 32010001617 Date abstract record published 08/12/2010 Health Technology Assessment (HTA) database Copyright © 2019 Agency for Healthcare Research and Quality (AHRQ

1999 Health Technology Assessment (HTA) Database.

258. Treatment of attention-deficit/hyperactivity disorder

/hyperactivity disorder. Rockville: Agency for Healthcare Research and Quality (AHRQ). Evidence Report/Technology Assessment No. 11. 1999 Authors' objectives To determine (a) the long-term and short-term effectiveness and safety of pharmacological and nonpharmacological interventions for attention-deficit/hyperactivity disorder (ADHD) in children and adults and (b) whether combined interventions are more effective than individual interventions. Authors' conclusions This report describes rigorous systematic (...) Treatment of attention-deficit/hyperactivity disorder Treatment of attention-deficit/hyperactivity disorder Treatment of attention-deficit/hyperactivity disorder Agency for Healthcare Research and Quality Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Agency for Healthcare Research and Quality. Treatment of attention-deficit

1999 Health Technology Assessment (HTA) Database.

259. Treatment of attention-deficit/hyperactivity disorder

Treatment of attention-deficit/hyperactivity disorder Treatment of attention-deficit/hyperactivity disorder Treatment of attention-deficit/hyperactivity disorder Jadad A R, Boyle M, Cunningham C, Kim M, Schachar R Authors' objectives To determine: 1. The long- and short-term effectiveness and safety of pharmacological and non-pharmacological interventions for attention-deficit/hyperactivity disorder (ADHD) in children and adults. 2. Whether combined interventions are more effective than (...) non-pharmacological for attention deficit hyperactivity disorder. Evid Based Med 2000;5:179. Indexing Status Subject indexing assigned by CRD MeSH Adrenergic Uptake Inhibitors /adverse effects /therapeutic use; Adult; Antidepressive Agents, Tricyclic /adverse effects /therapeutic use; Attention Deficit Disorder with Hyperactivity /drug therapy /therapy; Central Nervous System Stimulants /adverse effects /therapeutic use; Child; Child Behavior /drug effects; Combined Modality Therapy; Desipramine

1999 DARE.

260. A meta-analysis of clonidine for symptoms of attention-deficit hyperactivity disorder

A meta-analysis of clonidine for symptoms of attention-deficit hyperactivity disorder Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

1999 DARE.